Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-007023
Date:2021-02-02
Issuer: TRAVERE THERAPEUTICS, INC. (TVTX)
Original Submission Date:

Reporting Person:

ASELAGE STEVE
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300 SAN DIEGO, CA 92130

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-02 M 25,000 a $10.09 221,667 direct
COMMON STOCK 2021-02-02 S 25,000 d $30.75 196,667 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 10.09 2021-02-21 deemed execution date M 25,000 (d) 2024-11-05 common stock 25,000 $10.09 275,000 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to an automatic trading plan adopted in accordance with rule 10b5-1 of the securities exchange act of 1934.
f2 the stock option is fully vested and exercisable.

Elevate your investments